Cotelligent
This article was originally published in The Gray Sheet
Executive Summary
FDA market go-ahead for the Ortho Summit system and processor makes it "the first automated system for blood and plasma screening cleared by the FDA," Cotelligent maintains. Developed in conjunction with Ortho Clinical Diagnostics, the system is designed to screen blood products for hepatitis and retroviruses, including HIV and HTLV. Initial installations are anticipated by year-end